
WADA invites applications for research projects on the development of gene doping detection methods
The World Anti-Doping Agency (WADA) is pleased to inform you of a call for research projects on the theme of Gene Doping Detection that...

JOIN SFTCG'S WEBINAR SERIES ON GENE EDITING AND GENE THERAPY
SFTCG's next webinar series begins on 10 February with 'An introduction to gene editing for gene therapy applications'.


ESGCT 2022 HEADLINE NUMBERS
View a summary of our headline numbers and achievements in 2022.


ESGCT SUPPORTING MASTERS STUDENTS
See how the BME Paris Master's Programme students have benefitted from ESGCT activities!

SCIENTIFIC CALL FOR PROPOSALS AFM-TELETHON 2023
This INTERNATIONAL Call for Proposals, open to both French and foreign teams.


IMPORTANT NEWS TO SHARE WITH US?
ESGCT members are invited to send their news items to share via our website and social media.


FIRST CONDITIONAL MARKETING AUTHORIZATION APPROVAL IN THE EU FOR HEMOPHILIA "A" GENE THERAPY
Thierry VandenDriessche(1), Steven W Pipe(2), Glenn F Pierce(3), Radoslaw Kaczmarek(4) 1. Department of Gene Therapy & Regenerative...

NEW EUROPEAN CONSORTIUM - AGORA
A new Europe-wide academic initiative, named AGORA (Access to Gene therapies fOr RAre disease), has been launched.

ERC HORIZON EUROPE 2023 SUBMISSION DATES
€2.2 billion will be made available by the ERC in 2023 to allow over 1,000 top researchers to pursue frontier research.

REVIEW ARTICLE: TOWARDS ACCESS FOR ALL
1st Working Group Report for the Global Gene Therapy Initiative (GGTI).